ABBOTT LABORATORIES — Director's Dealing 2005

Feb 10, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ICAGEN INC (ICGN)
CIK: 0000902622
Period of Report: 2005-02-08

Reporting Person: ABBOTT LABORATORIES (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-02-08	Common Stock	C	1191300	—	Acquired	1191300	Direct
2005-02-08	Common Stock	C	455235	—	Acquired	1646535	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-02-08	Series E Convertible Preferred Stock	$	C	1191300	Disposed		Common Stock (1191300)	Direct
2005-02-08	Series E-1 Convertible Preferred Stock	$	C	400000	Disposed		Common Stock (455235)	Direct

Footnotes

F1: Upon the closing of the Issuer's public offering, the Series E Convertible Preferred Stock converted on a 1-for-1 basis into Common Stock.

F2: Upon the closing of the Issuer's public offering, the Series E-1 Convertible Preferred Stock converted on a 1.138-for-1 basis into Common Stock.

F3: These shares were immediately exercisable. They had no expiration date.